The demand for Mounjaro, and to a lesser extent Wegovy, was swift and vast, but uptake was not isolated to those products alone
The Risks: Muscle Loss on GLP-1s GLP-1 medications have shown remarkable results, with many patients losing 1520% of their body weight within a year
Medical Community Response The emerging evidence of adverse gastric effects associated with these drugs has prompted the medical community to reassess their safety profile
Similar content being viewed by others Main In the mid-1970s, it was noticed that the world's supply of blood was contaminated with an unidentified agent causing post-transfusion non-A, non-B hepatitis 1
You should always consult with your physician before stopping or changing medications or taking on new health strategies
--- The Caution The caution is the same one that applies to almost every interesting peptide study: Mechanism is not the same as finished clinical utility